Get startedLog in
    Picture of Cohance Lifesciences logo

    COHANCE — Cohance Lifesciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: India's Suven Pharmaceuticals Dec-Quarter Consol Net Profit Rises

    Picture of Cohance Lifesciences logoCohance Lifesciences
    08/02/2022 07:52
    Feb 8 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * DEC-QUARTER CONSOL NET PROFIT 1.60 BILLION RUPEES VERSUS
1.14
BILLION RUPEES YEAR AGO
    * DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 3.92 BILLION
RUPEES
VERSUS 2.75 BILLION RUPEES YEAR AGO
    * DECLARED INTERIM DIVIDEND OF 1 RUPEE/SHARE
    * APPOINTS J. V. RAMUDU AS CHAIRPERSON
    * BOARD GAVE IN-PRINCIPLE NOD TO  EVALUATE ACQUISITION OF
CASPER
PHARMA

Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cohance Lifesciences

    See all news